CNSY
Price:
$2.03
Market Cap:
$13.97M
Plus Therapeutics, Inc. is a clinical-stage pharmaceutical company. The firm focuses on the development of chemotherapeutics and radio therapeutics for rare cancers that address unmet medical and market needs. Its products include Rhenium NanoLiposome and DocePLUS. The company was founded by Ralph E. Holmes and Christopher J. Calhoun in July 1996 and is headquartered in Houston, TX.
Industry
Medical - Pharmaceuticals
IPO Date
2026-08-03
Stock Exchange
NASDAQ
Ticker
CNSY
According to Cerenome, Inc.’s latest financial reports and current stock price. The company's current Enterprise Value is 11.65M. This represents a change of -1.98% compared to the average of 11.89M of the last 4 quarters.
The mean historical Enterprise Value of Cerenome, Inc. over the last ten years is -794407.58. The current 11.65M Enterprise Value has changed -146759.14% with respect to the historical average. Over the past ten years (40 quarters), CNSY's Enterprise Value was at its highest in in the June 2026 quarter at 25.11M. The Enterprise Value was at its lowest in in the March 2022 quarter at -14457767.72.
Average
-794407.58
Median
1.36M
Minimum
-12364716.44
Maximum
8.94M
Discovering the peaks and valleys of Cerenome, Inc. Enterprise Value, unveiling quarterly and yearly fluctuations to gain insights into the company’s financial performance and market dynamics, offering valuable data for investors and analysts alike.
Maximum Annual Increase = 744.98%
Maximum Annual Enterprise Value = 8.94M
Minimum Annual Increase = -199.87%
Minimum Annual Enterprise Value = -12364716.44
| Year | Enterprise Value | Change |
|---|---|---|
| 2025 | 4.67M | 6.88% |
| 2024 | 4.37M | -199.87% |
| 2023 | -4372491.17 | -64.64% |
| 2022 | -12364716.44 | 8.40% |
| 2021 | -11406869.63 | 744.98% |
| 2020 | -1349952.18 | -75.80% |
| 2019 | -5578985.05 | -162.40% |
| 2018 | 8.94M | 119.46% |
| 2017 | 4.07M | -19.80% |
| 2016 | 5.08M | 114.72% |
The current Enterprise Value of Cerenome, Inc. (CNSY) is greater than its 3-year, greater than its 5-year, and greater than its 10-year historical averages
3-year avg
1.55M
5-year avg
-3822002.31
10-year avg
-794407.58
Cerenome, Inc.’s Enterprise Value is
| Company | Enterprise Value | Market cap |
|---|
One of the best ways to find valuable stocks to invest in is to build a custom made screener in your Excel or Google Sheets spreadsheet. This allows you to compare thousands of companies like Cerenome, Inc. using the financials and key metrics that matter to you in a single view.
The easiest way to set this up is to use the Wisesheets add-on and set your spreadsheet like this:
Covering all these metrics from financial, data, dividend data, key metrics and more you can get all the data you want for over 50+ exchanges worldwide.
Get your free trial here.
The easiest way to analyze a company like Cerenome, Inc. or any others is to create a spreadsheet model that automatically retrieves all of the stock data you need.
Using Wisesheets you can set up a spreadsheet model like this with simple spreadsheet formulas. If you change the ticker you can get all of the data automatically updated for you.
Whether you need live data, historical price data, financials, dividend data, key metrics, analyst estimates, or anything else...Wisesheets has you covered.
What is the Enterprise Value?
How can you use the Enterprise Value?
What is Cerenome, Inc.'s Enterprise Value?
What is the highest Enterprise Value for Cerenome, Inc. (CNSY)?
What is the 3-year average Enterprise Value for Cerenome, Inc. (CNSY)?
What is the 5-year average Enterprise Value for Cerenome, Inc. (CNSY)?
How does the current Enterprise Value for Cerenome, Inc. (CNSY) compare to its historical average?